Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • Alphaアッセイ
  • AlphaLISA Human TREM2 Detection Kit, 100 Assay Points

AlphaLISA Human TREM2 Detection Kit, 100 Assay Points

AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Human TREM2 Detection Kit, 100 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button

This kit replaces AL3109. The AlphaLISA™ immunoassay kit for human TREM2 enables the quantitative determination of human soluble TREM2 in buffer, cell culture media, serum, cell lysates and cell supernatants using a homogeneous AlphaLISA assay (no wash steps). The antibodies in the kit recognize the extracellular domain of TREM2.

View product information
Feature Specification
Application タンパク質定量
Dynamic Range 4 - 100,000 pg/mL  
Limit of Detection 4.3 pg/mL  
Limit of Quantification 13.8 pg/mL  
Sample Volume 10 µL

This kit replaces AL3109. The AlphaLISA™ immunoassay kit for human TREM2 enables the quantitative determination of human soluble TREM2 in buffer, cell culture media, serum, cell lysates and cell supernatants using a homogeneous AlphaLISA assay (no wash steps). The antibodies in the kit recognize the extracellular domain of TREM2.

View product information
Product variants
Unit Size: 100 assay points
Part #:
AL3152HV
Unit Size: 500 assay points
Part #:
AL3152C
Unit Size: 5,000 assay points
Part #:
AL3152F
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Human TREM2 Detection Kit, 100 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead
AlphaLISA Human TREM2 Detection Kit, 100 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
Quick links
  • Variants
  • Video
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Customers also bought
  • Get help

Product information

  • Overview
  • How it works
  • Specifications
  • Video gallery

Overview

TREM-2 is known as Triggering Receptor Expressed on Myeloid Cells 2. The TREM family of receptors regulates the activity of various cell types of the immune system, including neutrophils, monocyte/macrophages, microglia, and dendritic cells. Soluble TREM-2 has been detected in human cerebrospinal fluid (CSF), where it was found to be elevated in patients with multiple sclerosis and other inflammatory neurological conditions in comparison to patients without inflammatory neurologic disorders.

Formats
  • Our HV (100 assay point) kits allow you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
Feature:
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

How it works

Principle of the AlphaLISA assay

The AlphaLISA assay is based on an AlphaLISA sandwich immunoassay involving a biotinylated anti-analyte antibody bound to Streptavidin-coated AlphaLISA Donor beads and an anti-analyte antibody conjugated to AlphaLISA Acceptor beads. Both antibodies are directed against the analyte of interest. In the presence of the target, both antibodies bind to analyte and the beads come into proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer within the Acceptor beads, resulting in emission with λmax at 615 nm. The intensity of the signal is directly proportional to the concentration of analyte present in the sample.

Assay Principle AlphaLISA

 

Protocol of the AlphaLISA assay

The AlphaLISA assay can be run in a 96- or 384-well detection plate (50 µL final). As described here, samples or standards are dispensed directly into the assay plate for the detection of the analyte of interest by AlphaLISA reagents. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

AlphaLISA 3-step assay protocol, acceptor bead first

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
4 - 100,000 pg/mL  
Limit of Detection
4.3 pg/mL  
Limit of Quantification
13.8 pg/mL  
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
TREM2
Target Class
Biomarkers
Target Species
Human
Technology
Alpha
Therapeutic Area
Central Nervous System
Unit Size
100 assay points

Video gallery

AlphaLISA Human TREM2 Detection Kit, 100 Assay Points
AlphaLISA Human TREM2 Detection Kit, 100 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Guide:-:1
  • Infographic:-:1
1-2 of 2 Resources
Guide Icon
Guide
Download your guide about neurodegenerative diseases

Emerging pathways to neuroinflammation and neurodegeneration

Neurodegenerative diseases, such as amyotrophic lateral sclerosis...

Learn more
Infographic Icon
Infographic
Neurodegeneration and associated diseases

See this infographic for a summary on the key diseases related to neurodegeneration, associated risk factors, and specific cell...

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.